Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Expectoration | Research

Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease

Authors: Terence Ho, Matthew Nichols, Gayatri Nair, Katherine Radford, Melanie Kjarsgaard, Chynna Huang, Anurag Bhalla, Nicola Lavigne, Manali Mukherjee, Michael Surette, Joseph Macri, Parameswaran Nair

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

Excess pulmonary iron has been implicated in the pathogenesis of lung disease, including asthma and COPD. An association between higher iron content in sputum macrophages and infective exacerbations of COPD has previously been demonstrated.

Objectives

To assess the mechanisms of pulmonary macrophage iron sequestration, test the effect of macrophage iron-loading on cellular immune function, and prospectively determine if sputum hemosiderin index can predict infectious exacerbations of COPD.

Methods

Intra- and extracellular iron was measured in cell-line-derived and in freshly isolated sputum macrophages under various experimental conditions including treatment with exogenous IL-6 and hepcidin. Bacterial uptake and killing were compared in the presence or absence of iron-loading. A prospective cohort of COPD patients with defined sputum hemosiderin indices were monitored to determine the annual rate of severe infectious exacerbations.

Results

Gene expression studies suggest that airway macrophages have the requisite apparatus of the hepcidin-ferroportin axis. IL-6 and hepcidin play roles in pulmonary iron sequestration, though IL-6 appears to exert its effect via a hepcidin-independent mechanism. Iron-loaded macrophages had reduced uptake of COPD-relevant organisms and were associated with higher growth rates. Infectious exacerbations were predicted by sputum hemosiderin index (β = 0.035, p = 0.035).

Conclusions

We demonstrate in-vitro and population-level evidence that excess iron in pulmonary macrophages may contribute to recurrent airway infection in COPD. Specifically, IL-6-dependent iron sequestration by sputum macrophages may result in immune cell dysfunction and ultimately lead to increased frequency of infective exacerbation.
Appendix
Available only for authorised users
Literature
1.
go back to reference O’Donnell DE, Aaron SD, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2007 update. Can Respir J. 2007;14:5B-32B.CrossRef O’Donnell DE, Aaron SD, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2007 update. Can Respir J. 2007;14:5B-32B.CrossRef
2.
go back to reference Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med. 2017;195:557–82.CrossRef Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med. 2017;195:557–82.CrossRef
3.
go back to reference Connors AF, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 1996;154:959–67.CrossRef Connors AF, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 1996;154:959–67.CrossRef
4.
go back to reference Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384(9944):691–702.CrossRef Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384(9944):691–702.CrossRef
5.
go back to reference Reid DW, Anderson GJ, Lamont IL. Role of lung iron in determining the bacterial and host struggle in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2009;297(5):L795–802.CrossRef Reid DW, Anderson GJ, Lamont IL. Role of lung iron in determining the bacterial and host struggle in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2009;297(5):L795–802.CrossRef
6.
go back to reference Nairz M, Schroll A, Demetz E, Tancevski I, Theurl I, Weiss G. “Ride on the ferrous wheel”—The cycle of iron in macrophages in health and disease. Immunobiology. 2015;220(2):280–94.CrossRef Nairz M, Schroll A, Demetz E, Tancevski I, Theurl I, Weiss G. “Ride on the ferrous wheel”—The cycle of iron in macrophages in health and disease. Immunobiology. 2015;220(2):280–94.CrossRef
7.
go back to reference Winter WE, Bazydlo LAL, Harris NS. The Molecular biology of human iron metabolism. Lab Med. 2014;45(2):92–102.CrossRef Winter WE, Bazydlo LAL, Harris NS. The Molecular biology of human iron metabolism. Lab Med. 2014;45(2):92–102.CrossRef
8.
go back to reference Nguyen NB. Hepcidin expression and iron transport in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2006;291(3):L417–25.CrossRef Nguyen NB. Hepcidin expression and iron transport in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2006;291(3):L417–25.CrossRef
9.
go back to reference Deschemin J-C, Mathieu JRR, Zumerle S, Peyssonnaux C, Vaulont S. pulmonary iron homeostasis in hepcidin knockout mice. Front Physiol. 2017;8:359–414.CrossRef Deschemin J-C, Mathieu JRR, Zumerle S, Peyssonnaux C, Vaulont S. pulmonary iron homeostasis in hepcidin knockout mice. Front Physiol. 2017;8:359–414.CrossRef
10.
go back to reference Pelusi S, Girelli D, Rametta R, Campostrini N, Alfieri C, Traglia M, et al. The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. BMC Nephrol. 2013;14(1):1–1.CrossRef Pelusi S, Girelli D, Rametta R, Campostrini N, Alfieri C, Traglia M, et al. The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. BMC Nephrol. 2013;14(1):1–1.CrossRef
11.
go back to reference Ali MK, Kim RY, Brown AC, Donovan C, Vanka KS, Mayall JR, et al. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease. J Pathol. 2020;251(1):49–62.CrossRef Ali MK, Kim RY, Brown AC, Donovan C, Vanka KS, Mayall JR, et al. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease. J Pathol. 2020;251(1):49–62.CrossRef
12.
go back to reference Ali MK, Kim RY, Brown AC, Mayall JR, Karim R, Pinkerton JW, et al. Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma. Eur Respir J. 2020;55(4):1901340.CrossRef Ali MK, Kim RY, Brown AC, Mayall JR, Karim R, Pinkerton JW, et al. Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma. Eur Respir J. 2020;55(4):1901340.CrossRef
13.
go back to reference Philippot Q, Deslée G, Adair-Kirk TL, Woods JC, Byers D, Conradi S, et al. Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. PLoS ONE. 2014;9(5):e96285.CrossRef Philippot Q, Deslée G, Adair-Kirk TL, Woods JC, Byers D, Conradi S, et al. Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. PLoS ONE. 2014;9(5):e96285.CrossRef
14.
go back to reference Zhang WZ, Oromendia C, Kikkers SA, Butler JJ, Beirne SOX, Kim K, et al. Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS. Sci Rep. 2020;10:1–13.CrossRef Zhang WZ, Oromendia C, Kikkers SA, Butler JJ, Beirne SOX, Kim K, et al. Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS. Sci Rep. 2020;10:1–13.CrossRef
15.
go back to reference Cloonan SM, Glass K, Laucho-Contreras ME, Bhashyam AR, Cervo M, Pabón MA, et al. Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nat Med. 2016;22(2):163–74.CrossRef Cloonan SM, Glass K, Laucho-Contreras ME, Bhashyam AR, Cervo M, Pabón MA, et al. Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nat Med. 2016;22(2):163–74.CrossRef
16.
go back to reference Kao J-K, Wang S-C, Ho L-W, Huang S-W, Chang S-H, Yang R-C, et al. Chronic iron overload results in impaired bacterial killing of THP-1 derived macrophage through the inhibition of lysosomal acidification. PLoS ONE. 2016;11(5):e0156713.CrossRef Kao J-K, Wang S-C, Ho L-W, Huang S-W, Chang S-H, Yang R-C, et al. Chronic iron overload results in impaired bacterial killing of THP-1 derived macrophage through the inhibition of lysosomal acidification. PLoS ONE. 2016;11(5):e0156713.CrossRef
17.
go back to reference Zhou H, Kobzik L. Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2007;36(4):460–5.CrossRef Zhou H, Kobzik L. Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2007;36(4):460–5.CrossRef
18.
go back to reference Bedi P, Chalmers JD, Goeminne PC, Mai C, Saravanamuthu P, Velu PP, et al. The BRICS (Bronchiectasis Radiologically Indexed CT Score): a multicenter study score for use in idiopathic and postinfective bronchiectasis. Chest. 2018;153(5):1177–86.CrossRef Bedi P, Chalmers JD, Goeminne PC, Mai C, Saravanamuthu P, Velu PP, et al. The BRICS (Bronchiectasis Radiologically Indexed CT Score): a multicenter study score for use in idiopathic and postinfective bronchiectasis. Chest. 2018;153(5):1177–86.CrossRef
19.
go back to reference Pizzichini E, Pizzichini MMM, Efthimiadis AE, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154:308–17.CrossRef Pizzichini E, Pizzichini MMM, Efthimiadis AE, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154:308–17.CrossRef
20.
go back to reference Kim LH-Y, Plaza K, Thomas SR, Draijer C, Radford K, Peters-Golden M, et al. Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs. J Immunol Methods. 2018;454:76–9.CrossRef Kim LH-Y, Plaza K, Thomas SR, Draijer C, Radford K, Peters-Golden M, et al. Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs. J Immunol Methods. 2018;454:76–9.CrossRef
21.
go back to reference Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Int Med. 1987;106(2):196–204.CrossRef Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Int Med. 1987;106(2):196–204.CrossRef
22.
go back to reference Sadatsafavi M, Sin DD, Zafari Z, Criner G, Connett JE, Lazarus S, et al. The Association between rate and severity of exacerbations in chronic obstructive pulmonary disease: an application of a joint frailty-logistic model. Am J Epidemiol. 2016;184(9):681–9.CrossRef Sadatsafavi M, Sin DD, Zafari Z, Criner G, Connett JE, Lazarus S, et al. The Association between rate and severity of exacerbations in chronic obstructive pulmonary disease: an application of a joint frailty-logistic model. Am J Epidemiol. 2016;184(9):681–9.CrossRef
23.
go back to reference Frazier MD, Mamo LB, Ghio AJ, Turi JL. Hepcidin expression in human airway epithelial cells is regulated by interferon-γ. Respir Res. 2011;12(1):100.CrossRef Frazier MD, Mamo LB, Ghio AJ, Turi JL. Hepcidin expression in human airway epithelial cells is regulated by interferon-γ. Respir Res. 2011;12(1):100.CrossRef
24.
go back to reference Lim D, Kim KS, Jeong J-H, Marques O, Kim H-J, Song M, et al. The hepcidin-ferroportin axis controls the iron content of Salmonella-containing vacuoles in macrophages. Nat Commun. 2018;9(1):1–12.CrossRef Lim D, Kim KS, Jeong J-H, Marques O, Kim H-J, Song M, et al. The hepcidin-ferroportin axis controls the iron content of Salmonella-containing vacuoles in macrophages. Nat Commun. 2018;9(1):1–12.CrossRef
25.
go back to reference Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. Iron depletion limits intracellular bacterial growth in macrophages. Blood. 2008;112(3):866–74.CrossRef Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. Iron depletion limits intracellular bacterial growth in macrophages. Blood. 2008;112(3):866–74.CrossRef
26.
go back to reference Mohan S, Ho T, Kjarsgaard M, Radford K, Borhan ASM, Thabane L, et al. Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study. BMC Pulm Med. 2017;17(1):60.CrossRef Mohan S, Ho T, Kjarsgaard M, Radford K, Borhan ASM, Thabane L, et al. Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study. BMC Pulm Med. 2017;17(1):60.CrossRef
27.
go back to reference Peyssonnaux C. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107(9):3727–32.CrossRef Peyssonnaux C. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107(9):3727–32.CrossRef
Metadata
Title
Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease
Authors
Terence Ho
Matthew Nichols
Gayatri Nair
Katherine Radford
Melanie Kjarsgaard
Chynna Huang
Anurag Bhalla
Nicola Lavigne
Manali Mukherjee
Michael Surette
Joseph Macri
Parameswaran Nair
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-01929-7

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.